|
US5849478A
(en)
*
|
1986-08-14 |
1998-12-15 |
Cashman; Daniel P. |
Blocked-polymerase polynucleotide immunoassay method and kit
|
|
US5723289A
(en)
*
|
1990-06-11 |
1998-03-03 |
Nexstar Pharmaceuticals, Inc. |
Parallel selex
|
|
ATE165397T1
(de)
*
|
1991-06-27 |
1998-05-15 |
Genelabs Tech Inc |
Screeningtest für den nachweis von dna-bindenden molekülen
|
|
US5726014A
(en)
*
|
1991-06-27 |
1998-03-10 |
Genelabs Technologies, Inc. |
Screening assay for the detection of DNA-binding molecules
|
|
US5578444A
(en)
*
|
1991-06-27 |
1996-11-26 |
Genelabs Technologies, Inc. |
Sequence-directed DNA-binding molecules compositions and methods
|
|
US6017696A
(en)
*
|
1993-11-01 |
2000-01-25 |
Nanogen, Inc. |
Methods for electronic stringency control for molecular biological analysis and diagnostics
|
|
US8153602B1
(en)
|
1991-11-19 |
2012-04-10 |
Isis Pharmaceuticals, Inc. |
Composition and methods for the pulmonary delivery of nucleic acids
|
|
US5616461A
(en)
*
|
1992-05-14 |
1997-04-01 |
Dana-Farber Cancer Institute |
Assay for antiviral activity using complex of herpesvirus origin of replication and cellular protein
|
|
US6436635B1
(en)
|
1992-11-06 |
2002-08-20 |
Boston University |
Solid phase sequencing of double-stranded nucleic acids
|
|
US5795714A
(en)
|
1992-11-06 |
1998-08-18 |
Trustees Of Boston University |
Method for replicating an array of nucleic acid probes
|
|
US6824976B1
(en)
*
|
1993-04-02 |
2004-11-30 |
Rigel Pharmaceuticals, Inc. |
Method for selective inactivation of viral replication
|
|
US20030099945A1
(en)
*
|
1994-09-20 |
2003-05-29 |
Invenux, Inc. |
Parallel selex
|
|
US5871902A
(en)
*
|
1994-12-09 |
1999-02-16 |
The Gene Pool, Inc. |
Sequence-specific detection of nucleic acid hybrids using a DNA-binding molecule or assembly capable of discriminating perfect hybrids from non-perfect hybrids
|
|
US20030104361A1
(en)
|
1997-09-29 |
2003-06-05 |
Susan Weininger |
Method of detection of nucleic acids with a specific sequence composition
|
|
US7803529B1
(en)
|
1995-04-11 |
2010-09-28 |
Sequenom, Inc. |
Solid phase sequencing of biopolymers
|
|
US20060063193A1
(en)
*
|
1995-04-11 |
2006-03-23 |
Dong-Jing Fu |
Solid phase sequencing of double-stranded nucleic acids
|
|
US5830655A
(en)
*
|
1995-05-22 |
1998-11-03 |
Sri International |
Oligonucleotide sizing using cleavable primers
|
|
WO1997001755A2
(en)
*
|
1995-06-26 |
1997-01-16 |
Perseptive Biosystems, Inc. |
High speed, automated, continuous flow, multi-dimensional molecular selection and analysis
|
|
WO1997009342A1
(en)
|
1995-09-08 |
1997-03-13 |
Scriptgen Pharmaceuticals, Inc. |
Screen for compounds with affinity for rna
|
|
JP2000501068A
(ja)
*
|
1995-09-12 |
2000-02-02 |
フィテラ シンビオン エイピーエス |
アクチノマイシンd類似体
|
|
US6514746B1
(en)
|
1995-09-15 |
2003-02-04 |
Essential Therapeutics, Inc. |
Staphylococcus aureus histidine protein kinase essential genes
|
|
US6037123A
(en)
|
1995-09-15 |
2000-03-14 |
Microcide Pharmaceuticals, Inc. |
Methods of screening for compounds active on Staphylococcus aureus target genes
|
|
US5989827A
(en)
*
|
1995-11-14 |
1999-11-23 |
Abbott Laboratories |
Use of nuclear magnetic resonance to design ligands to target biomolecules
|
|
US5891643A
(en)
*
|
1995-11-14 |
1999-04-06 |
Abbott Laboratories |
Use of nuclear magnetic resonance to design ligands to target biomolecules
|
|
US5698401A
(en)
*
|
1995-11-14 |
1997-12-16 |
Abbott Laboratories |
Use of nuclear magnetic resonance to identify ligands to target biomolecules
|
|
CA2279673A1
(en)
|
1995-12-15 |
1997-06-16 |
Enzo Therapeutics, Inc. |
Property effecting and/or property exhibiting constructs for the expression of non-native nucleic acids for therapeutic and diagnostic uses
|
|
US5747256A
(en)
*
|
1995-12-19 |
1998-05-05 |
Beckman Instruments, Inc. |
Homogeneous DNA probe titration assay
|
|
US6602657B1
(en)
|
1995-12-28 |
2003-08-05 |
Tropix, Inc. |
Multiple reporter gene assay
|
|
WO1997024457A1
(en)
|
1995-12-29 |
1997-07-10 |
Guilford Pharmaceuticals Inc. |
Method and kit for detection of multiple protein interactions
|
|
AU6757698A
(en)
|
1996-02-26 |
1998-10-30 |
California Institute Of Technology |
Stereochemical control of the dna binding affinity, sequence specificity, and orientation-preference of chiral hairpin polyamides in the minor groove
|
|
US6143901A
(en)
*
|
1996-07-31 |
2000-11-07 |
Genesoft, Inc. |
Complex formation between dsDNA and pyrrole imidazole polyamides
|
|
US6090947A
(en)
|
1996-02-26 |
2000-07-18 |
California Institute Of Technology |
Method for the synthesis of pyrrole and imidazole carboxamides on a solid support
|
|
US6635417B1
(en)
|
1996-07-31 |
2003-10-21 |
California Institute Of Technology |
Complex formation between DSDNA and oligomer of cyclic heterocycles
|
|
US6555692B1
(en)
|
1996-02-26 |
2003-04-29 |
California Institute Of Technology |
Preparation and use of bifunctional molecules having DNA sequence binding specificity
|
|
AU734715B2
(en)
|
1996-02-26 |
2001-06-21 |
California Institute Of Technology |
Improved polyamides for binding in the minor groove of double stranded DNA
|
|
US6506906B1
(en)
|
1996-02-26 |
2003-01-14 |
California Institute Of Technology |
Preparation and use of bifunctional molecules having DNA sequence binding specificity
|
|
US5955590A
(en)
*
|
1996-07-15 |
1999-09-21 |
Worcester Foundation For Biomedical Research |
Conjugates of minor groove DNA binders with antisense oligonucleotides
|
|
US5998140A
(en)
|
1996-07-31 |
1999-12-07 |
The Scripps Research Institute |
Complex formation between dsDNA and oligomer of cyclic heterocycles
|
|
US6331392B1
(en)
|
1997-03-05 |
2001-12-18 |
Anadys Pharmaceutical, Inc. |
Screen employing fluorescence anisotropy to identify compounds with affinity for nucleic acids
|
|
US6586661B1
(en)
*
|
1997-06-12 |
2003-07-01 |
North Carolina State University |
Regulation of quinolate phosphoribosyl transferase expression by transformation with a tobacco quinolate phosphoribosyl transferase nucleic acid
|
|
US5939261A
(en)
*
|
1997-06-24 |
1999-08-17 |
Sarnoff Corporation |
Method for capturing a nucleic acid
|
|
US5972650A
(en)
*
|
1997-06-26 |
1999-10-26 |
Brigham And Women's Hospital |
Tetracycline repressor regulated mammalian cell transcription and viral replication switch
|
|
EP1012331B1
(de)
|
1997-07-01 |
2006-03-29 |
Isis Pharmaceuticals, Inc. |
Zusammensetzungen und verfahren zur verabreichung von oligonukleotiden über die speiseröhre
|
|
EP1003911A1
(de)
|
1997-07-14 |
2000-05-31 |
Valentis Inc. |
Verfahren zur identifizierung von synthetischen zell-oder gewebsspezifischen transkriptions-regulierten regionen
|
|
US6326489B1
(en)
|
1997-08-05 |
2001-12-04 |
Howard Hughes Medical Institute |
Surface-bound, bimolecular, double-stranded DNA arrays
|
|
EP1015889A1
(de)
*
|
1997-09-12 |
2000-07-05 |
Genelabs Technologies, Inc. |
Dsrna/dsrna-bindung- proteine-verfahren und zusammensetsungen
|
|
WO1999019510A1
(en)
*
|
1997-10-10 |
1999-04-22 |
President And Fellows Of Harvard College |
Surface-bound, double-stranded dna protein arrays
|
|
US6432360B1
(en)
|
1997-10-10 |
2002-08-13 |
President And Fellows Of Harvard College |
Replica amplification of nucleic acid arrays
|
|
US6485944B1
(en)
|
1997-10-10 |
2002-11-26 |
President And Fellows Of Harvard College |
Replica amplification of nucleic acid arrays
|
|
US6511803B1
(en)
|
1997-10-10 |
2003-01-28 |
President And Fellows Of Harvard College |
Replica amplification of nucleic acid arrays
|
|
WO1999042621A2
(en)
*
|
1998-02-21 |
1999-08-26 |
Tm Technologies, Inc. |
Methods for identifying or characterising a site based on the thermodynamic properties of nucleic acids
|
|
EP0945507A1
(de)
*
|
1998-03-27 |
1999-09-29 |
Boehringer Mannheim Gmbh |
Tumorspezifische Expressionskontrollregion und deren Verwendung
|
|
US20040186071A1
(en)
*
|
1998-04-13 |
2004-09-23 |
Bennett C. Frank |
Antisense modulation of CD40 expression
|
|
US7321828B2
(en)
|
1998-04-13 |
2008-01-22 |
Isis Pharmaceuticals, Inc. |
System of components for preparing oligonucleotides
|
|
AU745880B2
(en)
*
|
1998-05-21 |
2002-04-11 |
Isis Pharmaceuticals, Inc. |
Compositions and methods for non-parenteral delivery of oligonucleotides
|
|
CA2329252A1
(en)
*
|
1998-05-21 |
1999-11-25 |
Isis Pharmaceuticals Inc. |
Compositions and methods for topical delivery of oligonucleotides
|
|
US6723517B1
(en)
*
|
1998-06-02 |
2004-04-20 |
Minerva Biotechnologies Corporation |
Use of self-assembled monolayers to probe the structure of a target molecule
|
|
US6100035A
(en)
*
|
1998-07-14 |
2000-08-08 |
Cistem Molecular Corporation |
Method of identifying cis acting nucleic acid elements
|
|
US6203990B1
(en)
*
|
1998-11-06 |
2001-03-20 |
Mitokor |
Method and system for pattern analysis, such as for analyzing oligonucleotide primer extension assay products
|
|
DE69834208T2
(de)
*
|
1998-12-10 |
2007-01-25 |
Daniel P. El Dorado Hills Cashman |
Blockierte polymerase polynukleotid-immunoassay und kit
|
|
US7189506B1
(en)
|
1999-03-03 |
2007-03-13 |
Genelabs Technologies, Inc. |
DNA binding compound-mediated molecular switch system
|
|
US7932213B2
(en)
*
|
1999-05-11 |
2011-04-26 |
President And Fellows Of Harvard College |
Small molecule printing
|
|
US6824987B1
(en)
|
1999-05-11 |
2004-11-30 |
President And Fellows Of Harvard College |
Small molecule printing
|
|
DE19926216A1
(de)
*
|
1999-06-09 |
2001-02-22 |
Metallgesellschaft Ag |
Verfahren zur Herstellung von Bariumsulfat, Bariumsulfat und Verwendung des Bariumsulfats
|
|
US6677160B1
(en)
|
1999-09-29 |
2004-01-13 |
Pharmacia & Upjohn Company |
Methods for creating a compound library and identifying lead chemical templates and ligands for target molecules
|
|
US6764858B2
(en)
|
1999-09-29 |
2004-07-20 |
Pharmacia & Upjohn Company |
Methods for creating a compound library
|
|
WO2001025417A2
(en)
*
|
1999-10-01 |
2001-04-12 |
Sangamo Biosciences, Inc. |
Dna library and its use in methods of selecting and designing polypeptides
|
|
AU2001229576A1
(en)
*
|
2000-01-15 |
2001-07-24 |
Genelabs Technologies, Inc. |
Nucleic acid binding site assay and selection method
|
|
US6500436B2
(en)
|
2000-01-19 |
2002-12-31 |
Allergan, Inc. |
Clostridial toxin derivatives and methods for treating pain
|
|
US7138127B1
(en)
|
2000-01-19 |
2006-11-21 |
Allergan, Inc. |
Clostridial toxin derivatives and methods for treating pain
|
|
US6641820B1
(en)
|
2000-01-19 |
2003-11-04 |
Allergan, Inc. |
Clostridial toxin derivatives and methods to treat pain
|
|
WO2001079852A2
(en)
*
|
2000-04-17 |
2001-10-25 |
Pharmacia & Upjohn Company |
Nmr-methods for indentifying sites in papillomavirus e2 protein
|
|
WO2001083751A2
(en)
*
|
2000-04-28 |
2001-11-08 |
Sangamo Biosciences, Inc. |
Methods for binding an exogenous molecule to cellular chromatin
|
|
WO2001096607A2
(en)
|
2000-06-13 |
2001-12-20 |
The Trustees Of Boston University |
Use of nucleotide analogs in the analysis of oligonucleotide mixtures and in highly multiplexed nucleic acid sequencing
|
|
AU2001286843A1
(en)
*
|
2000-08-30 |
2002-03-13 |
North Carolina State University |
Transgenic plants containing molecular decoys that alter protein content therein
|
|
DE60128149D1
(en)
*
|
2000-11-07 |
2007-06-06 |
Univ North Carolina State |
Putrescin-n-methyltransferasepromotor
|
|
US20030003515A1
(en)
*
|
2000-12-05 |
2003-01-02 |
Farrell David H. |
Monocloral antibody-based diagnostic assay for gamma fibrinogen
|
|
US20030138782A1
(en)
*
|
2001-01-19 |
2003-07-24 |
Evans Glen A. |
Computer-directed assembly of a polynucleotide encoding a target polypeptide
|
|
WO2002086086A2
(en)
*
|
2001-04-25 |
2002-10-31 |
Wisconsin Alumni Research Foundation |
Methods to identify agents that bind the flap-tip helix of rna polymerase
|
|
US20060157072A1
(en)
*
|
2001-06-08 |
2006-07-20 |
Anthony Albino |
Method of reducing the harmful effects of orally or transdermally delivered nicotine
|
|
US20040214166A1
(en)
*
|
2001-06-08 |
2004-10-28 |
Xianqiang Li |
Method for identifying a disease state based on a detected mixture of activated transcription factors
|
|
US6696256B1
(en)
*
|
2001-06-08 |
2004-02-24 |
Pandmics, Inc. |
Method, array and kit for detecting activated transcription factors by hybridization array
|
|
US6821737B2
(en)
|
2001-06-08 |
2004-11-23 |
Panomics, Inc. |
Method for screening for drug candidates for modulating transcription factor activity
|
|
US6924113B2
(en)
|
2001-06-08 |
2005-08-02 |
Panomics, Inc. |
Method and kit for isolating DNA probes that bind to activated transcription factors
|
|
US7981842B2
(en)
|
2001-06-08 |
2011-07-19 |
Panomics, Inc. |
Method for detecting transcription factor-protein interactions
|
|
CN1638655A
(zh)
*
|
2001-06-08 |
2005-07-13 |
韦克多烟草有限公司 |
修饰烟草中烟碱和亚硝胺的水平
|
|
US7115232B2
(en)
*
|
2001-07-13 |
2006-10-03 |
Hudson Gordon S |
Fluorescence validation microplate and method of use
|
|
AU2002359761A1
(en)
*
|
2001-12-18 |
2003-06-30 |
Invenux, Inc. |
Antibiotic compounds
|
|
US7001718B2
(en)
*
|
2001-12-20 |
2006-02-21 |
Massachusetts Institute Of Technology |
Method of inhibiting pathogenicity of infectious agents
|
|
US20030143547A1
(en)
*
|
2002-01-24 |
2003-07-31 |
Xianqiang Li |
Method for identifying multiple activated transcription factors
|
|
EP1499188A4
(de)
*
|
2002-04-09 |
2007-11-14 |
Vector Tobacco Ltd |
Tabak mit weniger nikotin und nitrosaminen
|
|
DK1534830T3
(da)
|
2002-09-06 |
2011-02-14 |
Isogenica Ltd |
In vito-peptid-ekspressionsbibliotek
|
|
US8084432B2
(en)
*
|
2003-02-13 |
2011-12-27 |
Isis Pharmaceuticals, Inc. |
Compositions and methods for treatment of pouchitis
|
|
US7004001B2
(en)
*
|
2003-02-26 |
2006-02-28 |
Formcek Cleveland, Inc. |
Roll forming apparatus for forming sheet material into multiple shapes
|
|
US7750142B2
(en)
*
|
2003-04-28 |
2010-07-06 |
Isis Pharmaceuticals, Inc. |
Modulation of glucagon receptor expression
|
|
US7399853B2
(en)
|
2003-04-28 |
2008-07-15 |
Isis Pharmaceuticals |
Modulation of glucagon receptor expression
|
|
JP3711988B2
(ja)
*
|
2003-05-12 |
2005-11-02 |
株式会社日立製作所 |
微粒子アレー分析システム、微粒子アレーキットおよび化学分析方法
|
|
JP2007502112A
(ja)
*
|
2003-08-12 |
2007-02-08 |
ユニバーシティ オブ ユタ リサーチ ファウンデーション |
ヘパリン結合タンパク質:ヘパリン検出のためのセンサー
|
|
US20050142581A1
(en)
*
|
2003-09-04 |
2005-06-30 |
Griffey Richard H. |
Microrna as ligands and target molecules
|
|
WO2008013569A2
(en)
*
|
2006-01-03 |
2008-01-31 |
The President And Fellows Of Harvard College |
Small molecule printing
|
|
EP2020988B1
(de)
|
2006-04-28 |
2017-08-16 |
Children's Hospital Medical Center |
Zusammensetzungen mit fusogenen proteinen oder polypeptiden aus prosaposin zur anwendung auf transmembrane wirkstofffreisetzungssysteme
|
|
US8639445B2
(en)
*
|
2007-07-23 |
2014-01-28 |
Microsoft Corporation |
Identification of related residues in biomolecular sequences by multiple sequence alignment and phylogenetic analysis
|
|
CA2703364A1
(en)
*
|
2007-10-23 |
2009-04-30 |
Allergan, Inc. |
Methods of treating chronic neurogenic inflammation using modified clostridial toxins
|
|
US8916531B2
(en)
|
2007-11-20 |
2014-12-23 |
Isis Pharmaceuticals, Inc. |
Modulation of CD40 expression
|
|
US8889394B2
(en)
*
|
2009-09-07 |
2014-11-18 |
Empire Technology Development Llc |
Multiple domain proteins
|
|
KR20140007409A
(ko)
|
2011-01-28 |
2014-01-17 |
바이오디식스, 인크. |
호르몬 및 병용 요법을 위해 전이성 유방암 환자를 선택하기 위한 예측 시험
|
|
CA2849273C
(en)
|
2011-09-20 |
2020-07-21 |
Isis Pharmaceuticals, Inc. |
Antisense modulation of gcgr expression
|
|
JP2015502365A
(ja)
|
2011-12-12 |
2015-01-22 |
オンコイミューニン,インコーポレイティド |
オリゴヌクレオチドのイン−ビボ送達
|